LeMaitre Vascular, Inc.

LeMaitre Vascular, Inc. develops, manufactures, and markets medical devices and implants used in vascular surgery. The company serves the Americas, Europe, the Middle East, Africa, and the Asia Pacific. Its product portfolio includes allografts (cryopreserved human tissue grafts for vascular reconstruction and cardiac repair), embolectomy and thrombectomy catheters for removing blood clots, occlusion and perfusion catheters, and biologic products such as the Artegraft biologic graft for dialysis access. It also offers XenoSure, VascuCel, and CardioCel biologic patches for vessel closure and repair, carotid shunts, biosynthetic vascular grafts, a phlebectomy system for varicose veins, LifeSpan vascular grafts, radiopaque tape, and valvulotomes. Additionally, the company provides human cadaver tissue cryopreservation services.

LeMaitre Vascular, Inc. is listed on the Nasdaq Global Market (NasdaqGM) under the ticker symbol LMAT. Its shares are traded in United States Dollars (USD). The company is headquartered in the United States, and its stock is part of the US equity market.

LeMaitre Vascular operates in the Healthcare sector, specifically within the Medical Instruments & Supplies industry. This means the company designs, manufactures, and sells medical devices and supplies used by healthcare professionals, particularly in vascular surgery. Its products include surgical instruments, implants, and biologic grafts that are essential for procedures such as vessel repair, blood clot removal, and dialysis access.

LeMaitre Vascular serves a broad geographic footprint that includes the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. The company's products are used by vascular surgeons in these areas for a variety of procedures. While the company is based in the United States, its international presence allows it to distribute medical devices and implants globally, catering to hospitals and surgical centers across multiple continents.

LeMaitre Vascular offers a diverse range of products for vascular surgery. Key offerings include allografts (cryopreserved human tissue grafts for vascular reconstruction and cardiac repair), biologic grafts like the Artegraft (bovine carotid artery for dialysis access), and biologic patches such as XenoSure, VascuCel, and CardioCel for vessel closure and heart repair. The company also provides catheters (embolectomy, thrombectomy, occlusion, perfusion), carotid shunts, biosynthetic vascular grafts, a phlebectomy system for varicose veins, LifeSpan expanded polytetrafluoroethylene (ePTFE) grafts, radiopaque tape, and valvulotomes. Additionally, it offers human cadaver tissue cryopreservation services.